NeuAc(o2-3)Gal(Jl1-4)Glc/GlcNAc sequence as found in GM3 and in glycolipids of the neolacto series, but show a preference for the latter, longer sequences. Thus all four antibodies react with sialylated oligosaccharides containing i type (linear) and I type (branched) neolacto backbones. Fl antibody differs from the other three in its stronger reaction with branched neolacto sequences in accordance with its stronger agglutination of erythrocytes of I rather than i type. The four antibodies show a specificity for N-acetyl-rather than N-glycolyl-neuraminic acid.
Among the erythrocyte autoantibodies associated with cold agglutinin disease of man, several are known to be monoclonal antibodies directed against sialic acid-containing determinants (Roelcke, 1974) . These are distinct from the more commonly occurring monoclonal autoantibodies, anti-I and anti-i cold agglutinins, which do not require sialic acid and are directed against the developmentally regulated, branched and linear oligosaccharides of the poly(N-acetyl-lactosamine) (neolacto) series, respectively (Feizi, 1981) . Five Abbreviations used: NeuAc, N-acetylneuraminic acid; NeuGc, N-glycolylneuraminic acid; Gal, galactose; GlcNAc, N-acetyglucosamine; GalNAc, N-acetylgalactosamine; Glc, glucose; Cer, ceramide. t Present address: Department of Biochemistry, Institute of Adaptation Medicine, Shinshu University, Matsumoto 390, Japan.
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main types of sialic acid-dependent erythrocyte autoantibodies can be distinguished according to their agglutination reactions with native and proteinase-treated erythrocytes and with cells of I and i antigen types Roelcke et al., 1976 Roelcke et al., , 1977 Roelcke et al., , 1980 (icord) erythrocytes; the latter reacts well with adult erythrocytes of i type (Oadu1t), while the former resembles anti-I antibodies in its lack of reaction with iadult erythrocytes.
These sialic acid-recognizing antibodies are of considerable biological interest for, like the anti-I and anti-i antibodies (Feizi, 1982) , they have been found to detect some marked changes in antigenicity associated with cell differentiation in the mouse (K. Uemura, J. Pennington & T. Feizi, unpublished work) . Thus it will be important to know the precise antigenic determinants that they recognize.
In the present studies we have used the technique of immuno-t.l.c. to study the reactivities of eight sialic acid-dependent erythrocyte autoagglutinins with a variety of sialoglycolipids (gangliosides). With four autoantibodies of different types, anti-Pr2, anti-Gd, Sa and Fl, immunostaining was successfully achieved and an array of antigenically active glycolipids revealed. Evidence is presented that all four antibodies react to varying degrees with GNI3 and sialylated glycolipids of the neolacto series while anti-Pr2 reacts in addition with those of the ganglio series.
Experimental

Antibodies
The following antibodies from patients with cold agglutinin disease have been described previously: anti-Prl d (from patient Rob), anti-Prl h (patient RK), anti-Pr, (patient LTh) and anti-Pr3, anti-Gd (patient Kn); and antibodies of patients Sa, Fl and Lud (references are given in Table 1 ). The antibodies Sa and Fl were studied as eluates from human erythrocytes [absorbed at 4°C and eluted at 37°C as described previously (Roelcke, 1981a,b) ] and the others were studied using whole plasma. The information available on the immunoglobulin types, haemagglutination titres and the effect of proteinase treatment of erythrocytes on haemagglutination by these antibodies is summarized in Table 1 .
Gangliosides
The following gangliosides (structures shown in Table 2 ) were purified as described previously;
GMI from canine brain (Kunishita et al., 1979) ; GM2 from the brain of a Tay-Sachs disease patient (Kawamura & Taketomi, 1977) ; GDla, GDlb and GTIb from bovine brain (Momoi et al., 1976) .
Human erythrocyte gangliosides were prepared from pooled outdated blood group B erythrocyte stroma by chromatography of Folch upper phase lipids (Folch et al., 1957) on DEAE-Sephadex A-25 (Momoi et al., 1976) . The ganglioside fraction eluted with 0.05-0.1 M-ammonium acetate in methanol was used. Sialosylneolactotetraosylceramide, N-acetyl type (Siddiqui & Hakomori, 1973) , was purified from the human erythrocyte ganglioside mixture by preparative t.l.c. on a silica gel 60 HP-TLC plate (E. Merck, Darmstadt, Germany). A fraction of bovine erythrocyte gangliosides enriched in sialosylneolactotetraosylceramide, N-glycolyl type, and more complex gangliosides were prepared by silicic acid column chromatography (Uemura et al., 1978) . Sialosylneolactotetrasylceramide containing both N-glyco- NeuAc(a2-3)Gal(fl-4)Glc(/31-l)Cer+ + + NeuAc(a2-3)Gal(f1-4)GlcNAc(fll-3)Gal(fi-4)Glc(flI-1)Cer+ + + NeuAc(cx2-3)Gal(Pf-4)GlcNAc(j1-3)Gal(fl-4)GlcNAc(fIl-3)Gal(PI-4)Glc(/31-1)Cer+ + +t NeuAc(a2-3)Gal(fll-3)GalNAc(flI-4)Gal(PI-4)Glc(PI-1I)Cer Gal(fI-3)GalNAc(fI-4)Gal(fI-4)Glc(f3I-I)Cer (+) 12,3 lyl type (90%) and N-acetyl type (IO%) was purified as described previously (Uemura et al., 1978) . GM3 of N-acetyl and N-glycolyl types were separated (Uemura et al., 1978) from the bovine erythrocyte GM3 mixture by preparative t.l.c. as above. Human brain gangliosides were prepared according to Ledeen et al. (1973) Mollison (1979) . From erythrocyte membranes (Dodge et al., 1963) , glycolipids were extracted (Uemura et al., 1983) and evaporated to dryness. The dried residue was treated with 0.1 MNaOH for 1 h at room temperature and dialysed against water, evaporated and finally dissolved in chloroform/methanol (1:1, v/v).
Immuno-ti.c.
Glycolipids were chromatographed on HP-TLC plates (aluminium sheets, silica gel 60, E. Merck) using a solvent system of chloroform/ methanol/0.5% CaCl22H2O in water (11:9:2, by vol.). The following antibodies were used: anti-Pr2 (1:300 dilution in phosphate-buffered saline containing 5% albumin); Gd, Sa, anti-Prld and antiPrlh (1:100 dilution); Lud and anti-Pr3 (1:30 dilution); Fl (1:10 dilution). Normal serum supplemented with human immunoglobulin M (1Omg/ml) was used as a control (1: 50 dilution). The binding of antibodies to glycolipids on t.l.c. plates was detected by overlaying with the human autoantibodies followed by I 251-labelled rabbit immunoglobulins to human ju or a chains and autoradiography as described previously (Magnani et al., 1981; Uemura et al., 1983) .
In a preliminary experiment the effect of calcium ions on immunostaining by anti-Pr2 antibodies was studied. No difference was found in the intensity of immunostaining when 0.1 mMCaCl2 or 10mM-EDTA (tetrasodium salt) was added to the 5% albumin in phosphate-buffered saline used for the pretreatment of the plates and as a diluent of the antibodies.
Results
With four of the eight autoantibodies tested, anti-Pr2, anti-Gd, Sa The ability of anti-Pr2 to react with brain gangliosides was investigated further by immunostaining of purified components (Fig. 2) . This ( Vol. 219 antibody reacted very strongly with GM3 (structure 1, Table 2 ), strongly with GDla (structure 4), moderately strongly with GDlb and GT1b (structures 7 and 8) and weakly with preparations of GM2 and GM, (structures 9 and 10). These observations, together with the moderately strong reactivity of GD3 and GD2 (structures 5 and 6) in the human brain ganglioside mixture (Fig. 2B ) and the strong reaction of sialosylneolactotetraosylceramides (structure 2) of human and bovine erythrocytes (Figs. IA and 1B) and sialosylneolactohexaosylceramide (structure 3) of bovine erythrocytes (Fig.  IB) indicated that among the compounds tested the most optimal structure for reaction with this antibody is sialic acid joined by a2-3 linkage to a terminal Gal(fi-4)Glc/GlcNAc sequence. As summarized in Table 2 this antibody reacts less strongly with sialic acid a2-3-linked to a terminal Gal(#1-3)GalNAc sequence or to an internal galactose, as well as sialic acid a2-8-linked to another, internal sialic acid.
The immunostaining in the region of the Nacetyl rather than the N-glycolyl form of sialosylneolactotetraosylceramide and sialosylneolactohexaosylceramide of bovine erythrocyte gangliosides (Fig. 1 B) suggested that this antibody reacts with the N-acetyl analogues only. This was confirmed using preparations of GM3 and sialosylneolactotetraosylceramide. enriched for the Nacetyl or the N-glycolyl forms (Fig. 3) . In each case there was immunostaining of the N-acetyl forms only. Glycolipids expressing the Gd, Sa and Fl determinants
The determinants recognized by autoantibodies anti-Gd, Sa and Fl were lacking among brain gangliosides (Fig. IC) . But they were expressed among gangliosides of human and bovine erythrocytes (Figs. lA and 1 B) which are known to be predominantly of the neolacto-series (Chien et al., 1978; Hakomori, 1981) . The majority of immunoreactive glycolipid bands were clustered as two groups, the first migrating in the region of the GD1Ia standard and sialosylneolactohexaosylceramides and the second in the region of GDl b and GT1 b and slow migrating components corresponding to more complex gangliosides of the neolacto series Uemura et al., 1983) . Some reactivity in the region-of GN13 was also present (Fig. 1 A and   Fig. 4) . Several of the bands immunostained by these antibodies had identical mobilities to those reacting with anti-Pr2. However the relative intensities of immunostaining of these bands differed with the four antibodies as discussed below.
Anti-Gd, Sa and Fl resembled anti-Pr2 in their positive immunostaining of the N-acetyl form of sialosylneolactohexaosylceramide (structure 3) but not the N-glycolyl form (structure 13) of bovine erythrocytes (Fig. 1 B) .
Anti-Gd. Despite its lower haemagglutinating titre (Table 1) anti-Gd gave the strongest immunostaining with human erythrocyte gangliosides (Fig.  lA) , suggesting that it has a higher binding affinity than the other antibodies. Among the pool of gangliosides from blood group BI donors this antibody reacted with GM3 as well as a triplet of bands in the region of GD1a standard and sialosylneolactohexaosylceramide and a triplet of bands in the region of GDlb and GTlb corresponding to sialosylneolacto-octaosylceramides ( Fig. 1 A and  Fig. 4) . The slowest migrating component in the sialosylneolactohexaosylceramide region did not give immunostaining with anti-Pr2, Sa and Fl. This Gd-active component was not detected among the Folch upper phase glycolipids isolated from a single group 01 donor (Fig. 4) . Moreover the relative intensities of the other bands in the group 01 extract differed from those in the pooled group BI gangliosides.
Anti-Gd differed from anti-Pr2 in its stronger reaction with sialosylneolactohexaosylceramide of bovine erythrocytes than sialosylneolactotetraosylceramide (Fig. 1B) (Fig. 4) (Uemura et al., 1983) . The ability of antibody Fl to react with linear structures was confirmed by immunostaining of sialosylneolactohexaosylwith both the linear and branched structures but has a preference for the branched structures. An incidental observation was the lack of immunostaining in the neolactotetraosylceramide region in icord erythrocytes.
Discussion
These studies show the successful application of immuno-t.l.c. to reveal a family of N-acetylneuraminic acid containing gangliosides recognized by the monoclonal autoantibodies anti-Pr2, anti-Gd, Sa and Fl.
Anti-Pr2 was studied in the greatest detail. Because this antibody does not agglutinate papaintreated erythrocytes (Roelcke, 1974 it has been presumed that the antigenic determinant it recognizes is associated exclusively with the erythrocyte sialoglycoproteins. However, the present studies have clearly shown that this antibody reacts well with sialylated glycolipids (gangliosides) on thin layer chromatograms. Further investigations are required with glycolipid extracts from papain-treated erythrocytes to evaluate their glycolipids and to establish the relative roles of the glycoproteins and glycolipids in the haemagglutination reaction. It is possible that both the sialoglycoproteins and the gangliosides are required in a co-operative manner for haemagglutination to occur and the glycolipid-associated determinants remaining after removal of the glycopeptides may be too sparse for haemagglutination by this antibody. It is of interest that the Pr2 antigen of dog erythrocytes is unaffected by proteinase treatment (Roelcke, 1973b) .
Pr2 antibody gave immunostaining not only of erythrocyte gangliosides but of brain gangliosides also. This is in accord with the immunocytochemical studies of Romer etal. (1979) , which have shown that this antibody reacts with brain tissues of several mammalian species.
From the immunostaining reactions of anti-Pr2 with the several gangliosides of the neolacto and the ganglio series and GM3 ( Table 2 ) we deduce that the preferred sequence is NeuAc(a2-3)-Gal(f,l-4)GlcNAc/Glc, although this antibody may react with any ganglioside having the sequence NeuAc(a2-3)Gal or NeuAc(a2-8)-NeuAc(a2-3)Gal. Since these studies were completed we (P. Scudder & T. Feizi, unpublished work) have shown that anti-Pr2, but not anti-Gd, gives strong immunostaining of the NeuAc(a2-6) isomer of sialosylparagloboside with the sequence NeuAc(a2-6)Gal(,IB-4)GlcNAc(Pi1-3)Gal(fJ1-4)Glc-Cer ceramide isolated from chronic granulocytic isolated from human erythrocytes by Watanabe et leukaemia cells (Fig. 4) Our studies provide an explanation for previous inhibition data with this antibody. These have shown that haemagglutination of erythrocytes by anti-Pr2 can be inhibited by high concentrations of the a2-3 and a2-6 isomers of sialyl-lactose )Gal(,B1-4)Glc] (Tsai et al., 1977; Roelcke et al., 1980) as well as the oligosaccharides of sialoglycoproteins containing the sequence NeuAc(a2-3)Gal(,B1-3)GalNAc (Ebert et al., 1979) and the glycolipids GM3 and sialosylparagloboside (Tsai et al., 1977) .
In contrast to anti-Pr2, the antibodies Gd, Sa and Fl do not react with sialoglycolipids of the ganglio series but they react with the NeuAc(a2-3)-Gal(,Bl-4)Glc/G1cNAc sequences as found in the glycolipids of the neolacto series and GM3. Their immunostaining patterns indicate that they have a considerable preference for long chain structures with backbones of neolactohexaosyl-and longer ceramides.
Our observations that anti-Gd reacts with gangliosides in the region of the sialosylneolactohexaosylceramides (structure 3) of human and bovine erythrocytes (Figs. IA and IB) support those of Kundu et al. (1982) The intense reaction of anti-Gd with glycolipids having linear or branched backbones undoubtedly accounts for its lack of discrimination between cells of I and i types.
The majority of the gangliosides of human and bovine erythrocytes that gave immunostaining with antibodies Sa and Fl had mobilities identical to those of the components reacting with anti-Gd. Five of the bands in human erythrocytes and three in bovine erythrocytes also corresponded to those immunostained by anti-Pr2. A notable difference was the ganglioside in the pooled human erythrocytes of BI type migrating in the sialosylneolactohexaosylceramide region (between GD1a and GD1b) which reacted with anti-Gd but not with the other three antibodies (Figs. IA and 4) . This Gd-reactive component may correspond to the glycolipid isolated by Kundu et al. (1982) which inhibited haemagglutination by anti-Gd but not Sa. It will be of interest to perform structural studies of the three immunoreactive glycolipids in this sialosyl neolactohexaosylceramide region.
The preferential haemagglutination of I-rather than i-type erythrocytes by Fl antibody (Roelcke, 198 lb ; Table 1 ) suggested that this antibody might be directed against branched, sialylated oligosaccharides of the neolacto series (sialylated I antigen). However, on thin layer chromatograms this antibody was found to immunostain gangliosides of cells of I and i-type which are known to be predominantly branched in the former cells and linear in the latter (Fig. 1A and Fig. 4 ). Furthermore this antibody reacts with linear sialosylneolactohexaosylceramide of chronic granulocytic leukemia cells. Two observations indicated a preferential reaction with branched structures: (a) although the total counts bound by extracts from ladults icord and iadult erythrocytes were comparable, the 'adult cells gave more pronounced staining in the 'sialosyl-I' region of group 01 erythrocytes; (b) although this antibody gave immunostaining in the region of the major 'sialosyl-i' component (structure 3) of bovine erythrocytes (Fig. 1 B) , the reaction was weak in comparison with that seen with anti-Pr2, Gd and Sa. Thus, Fl antibody resembles certain anti-I antibodies, such as Step, Ver and Phi, which show preferential reactions with branched neolacto sequences but can react with linear glycolipid structures (Watanabe et al., Gal ( Feizi et al., 1979 ; K. Uemura, P. Hanfland, R. Childs & T. Feizi, unpublished work). After these studies were completed we were informed of the work of Kannagi et al. (1983) showing that fucosylated and branched sialoglycolipids with blood group A, H and B activities [as in structure 16 shown below (where R= Gal or GalNAc)] isolated from human erythrocytes react strongly with Fl antibody.
The differences in the immunostaining of the glycolipids obtained from pooled (outdated) blood group B blood versus those isolated from a fresh sample from a single group 0 donor deserve some comment. Apart from the blood group and other isotype differences, the possibility of degradative changes and inevitable contamination with leucocytes occurring in the outdated blood should be considered, for the buffy coat is readily separated Ra 11,3 Fuc(al-2)Gal(fl1-4)GlcNAc(f 1 \ 6) Gal(f1-4)GIcNAc(fi1-3)Gal(Il-4)Glc-Cer (16) 3) NeuAc(a2-3)Gal(fJ l-4)GlcNAc(fi1 / Our observations are in accord with that finding. However, a requirement for the fucose residue was assumed by Kannagi et al. (1983) , largely due to the failure of this antibody to react with the corresponding afucosyl ganglioside analogue derived from bovine erythrocytes. This observation must be interpreted with caution since the sialic acid associated with bovine erythrocytes is predominantly N-glycolylneuraminic acid (Uemura et al., 1978) which is not recognized by this antibody. This alone would account for a lack of reaction. Kannagi et al. (1983) did not specifically isolate the N-acetyl from the N-glycolylneuraminic acid form of this afucosyl analogue from bovine erythrocytes, although they estimated that it consisted predominantly of the N-acetylneuramic acid form (S. Hakomori, personal communication). Moreover, the enzymic removal of fucose residues from structure 16 may not be straightforward and it would be necessary to characterize structurally the afucosyl analogue thus obtained in order to establish the requirement for the fucose residue.
The differences in the relative intensities in immunostaining of the several bands by the four antibodies, suggest that each antibody reacts to a different extent with each component. However, it is conceivable that the glycolipid bands with identical mobilities in human erythrocytes immunostaining with the four antibodies (Fig. lA) consist of isomers with different structures. Structural studies of the purified components will be required to investigate this possibility. The differences in the fine specificities of these four autoantibodies would also account for the differences in their haemagglutination reactions with various types of native and proteinase-treated erythrocytes. Only certain of the glycolipids may be accessible to each antibody on the intact cell membranes, as suggested by Hakomori & Young (1978) . 
